FI880744A0 - PIPERAZINKARBOXYLSYRA, DESS FRAMSTAELLNING OCH DENNA INNEHAOLLANDE PHARMACEUTICAL PRODUCT. - Google Patents

PIPERAZINKARBOXYLSYRA, DESS FRAMSTAELLNING OCH DENNA INNEHAOLLANDE PHARMACEUTICAL PRODUCT.

Info

Publication number
FI880744A0
FI880744A0 FI880744A FI880744A FI880744A0 FI 880744 A0 FI880744 A0 FI 880744A0 FI 880744 A FI880744 A FI 880744A FI 880744 A FI880744 A FI 880744A FI 880744 A0 FI880744 A0 FI 880744A0
Authority
FI
Finland
Prior art keywords
piperazinkarboxylsyra
denna
pharmaceutical product
framstaellning och
dess framstaellning
Prior art date
Application number
FI880744A
Other languages
Finnish (fi)
Other versions
FI86733C (en
FI880744A (en
FI86733B (en
Inventor
Bernhard Aebischer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI880744A0 publication Critical patent/FI880744A0/en
Publication of FI880744A publication Critical patent/FI880744A/en
Application granted granted Critical
Publication of FI86733B publication Critical patent/FI86733B/en
Publication of FI86733C publication Critical patent/FI86733C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
FI880744A 1987-02-18 1988-02-17 ANALOGIFICATION OF THERAPEUTIC PREPARATION OF THERAPEUTIC ANALYSIS OF PIPERAZINKARBOXYLSYRA FI86733C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8703749 1987-02-18
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (4)

Publication Number Publication Date
FI880744A0 true FI880744A0 (en) 1988-02-17
FI880744A FI880744A (en) 1988-08-19
FI86733B FI86733B (en) 1992-06-30
FI86733C FI86733C (en) 1992-10-12

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880744A FI86733C (en) 1987-02-18 1988-02-17 ANALOGIFICATION OF THERAPEUTIC PREPARATION OF THERAPEUTIC ANALYSIS OF PIPERAZINKARBOXYLSYRA

Country Status (28)

Country Link
JP (1) JPH0723387B2 (en)
KR (1) KR960015190B1 (en)
AT (1) AT391320B (en)
AU (1) AU613009B2 (en)
BE (1) BE1002427A3 (en)
CA (1) CA1327799C (en)
CH (1) CH675125A5 (en)
CY (1) CY1739A (en)
DE (1) DE3804936C2 (en)
DK (1) DK168441B1 (en)
ES (2) ES2011319A6 (en)
FI (1) FI86733C (en)
FR (1) FR2610932B1 (en)
GB (2) GB8703749D0 (en)
GR (1) GR1002471B (en)
HK (1) HK142093A (en)
HU (2) HU199858B (en)
IE (1) IE59098B1 (en)
IL (1) IL85436A0 (en)
IT (1) IT1219447B (en)
LU (1) LU87129A1 (en)
MY (1) MY103206A (en)
NL (1) NL8800412A (en)
NZ (1) NZ223529A (en)
PH (1) PH25512A (en)
PT (1) PT86776B (en)
SE (1) SE467256B (en)
ZA (1) ZA881146B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
US6214604B1 (en) * 1995-05-08 2001-04-10 Lonza Ag Biotechnical production process of piperazine R-α-carboxylic acids and piperazine S-α-carboxylic acid amide
EA001904B1 (en) 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Arylsubstituted piperazines useful in the treatment of bening prostatic hyperplasia
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (en) 2006-11-08 2008-05-29 Nec Electronics Corp Semiconductor device and audio processor chip
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
JPH0723387B2 (en) 1995-03-15
PH25512A (en) 1991-07-24
ES2011319A6 (en) 1990-01-01
GB2201676A (en) 1988-09-07
SE467256B (en) 1992-06-22
CY1739A (en) 1995-10-20
ZA881146B (en) 1989-10-25
AT391320B (en) 1990-09-25
PT86776B (en) 1992-05-29
HK142093A (en) 1994-01-07
HUT49361A (en) 1989-09-28
FI86733C (en) 1992-10-12
DE3804936C2 (en) 1997-02-13
GR880100084A (en) 1988-12-16
SE8800541A (en) 1988-08-19
KR880009944A (en) 1988-10-06
ES2021904A6 (en) 1991-11-16
KR960015190B1 (en) 1996-11-01
GB8703749D0 (en) 1987-03-25
JPS63203691A (en) 1988-08-23
AU613009B2 (en) 1991-07-25
HU211269A9 (en) 1995-11-28
ATA36788A (en) 1990-03-15
GR1002471B (en) 1996-11-15
PT86776A (en) 1988-03-01
IL85436A (en) 1992-12-01
LU87129A1 (en) 1988-09-20
AU1175888A (en) 1988-08-25
IT1219447B (en) 1990-05-18
FR2610932A1 (en) 1988-08-19
DK79688A (en) 1988-08-19
IE880413L (en) 1988-08-18
MY103206A (en) 1993-05-29
GB2201676B (en) 1991-01-02
BE1002427A3 (en) 1991-02-05
IL85436A0 (en) 1988-07-31
IE59098B1 (en) 1994-01-12
DK79688D0 (en) 1988-02-16
IT8847631A0 (en) 1988-02-12
SE8800541D0 (en) 1988-02-17
GB8803438D0 (en) 1988-03-16
NL8800412A (en) 1988-09-16
FR2610932B1 (en) 1990-11-16
DK168441B1 (en) 1994-03-28
DE3804936A1 (en) 1988-09-01
CH675125A5 (en) 1990-08-31
NZ223529A (en) 1991-02-26
CA1327799C (en) 1994-03-15
FI880744A (en) 1988-08-19
HU199858B (en) 1990-03-28
FI86733B (en) 1992-06-30

Similar Documents

Publication Publication Date Title
FI842395A (en) 13 -ALKYLGONANER, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT.
DE69018647T2 (en) DRUG.
FI872114A0 (en) FOERFARANDE FOER TRYCKNING AV FORMADE PRODUCT HAERLEDDA FRAON ARAMIDFIBRER.
FI893340A0 (en) FOERFARANDE FOER ATT ERHAOLLA PHARMACEUTICAL SAMMANSAETTNINGAR FOER ATT HINDRA SMITTBARA KOENSSJUKDOMAR.
FI880195A0 (en) THERAPEUTIC PRODUCT.
FI894998A0 (en) CELLODLINGSPROCESSER, MATERIAL OCH PRODUKTER.
FI900035A (en) TIAZOLFOERENINGAR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL BLANDNINGAR.
FI862590A0 (en) PHARMACEUTICAL PRODUCT.
FI850455A0 (en) PHARMACEUTICAL PRODUCT.
FI880744A0 (en) PIPERAZINKARBOXYLSYRA, DESS FRAMSTAELLNING OCH DENNA INNEHAOLLANDE PHARMACEUTICAL PRODUCT.
FI863382A0 (en) SUBSTITUTE TOLUIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT OCH DERAS ANVAENDNING FOER HAEMMANDE AV MAGSYRASEKRET.
FI901938A0 (en) SILVERSULFADIAZINE INNEHAOLLANDE PHARMACEUTICAL PRODUCT FOER LOCAL EXTERNT BRUK.
FI883443A (en) FOERFARANDE OCH ANORDNING FOER ATT AOTSKILJA I FJAELLFORMATION INKOMMANDE PRODUKTER, ISYNNERHET TRYCKSAKER.
DE3763519D1 (en) MEDICINAL PRODUCTS.
FI863470A0 (en) 6-PHENOXIMETHYL-4-HYDROXITETRAHYDROPYRAN-2-ONER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL PHARMACEUTICAL PRODUCT AND CHARACTERISTICS.
FI844153L (en) 1,2-DITIOLANDERIVAT, DERAS FRAMSTAELLNINGSFOERFARANDE, DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT OCH DERAS ANVAENDNING.
FI905493A0 (en) NYA PYRIDINDERIVAT, DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT ORCHARANT FOR FOOD FRAMSTAELLNING.
DE3781045T2 (en) ANTIRHEUMATIC MEDICINAL PRODUCT.
FI885873A (en) LOESLIG REKOMBINANT-FC -RESEPTOR, DESS FRAMSTAELLNING OCH ANVAENDNING.
FI883320A0 (en) --LAKTAM, DESS FRAMSTAELLNING OCH MELLANPRODUKTER FOER DESS FRAMSTAELLNING.
FI900312A0 (en) NYA BENZOPYRANDERIVAT, DERAS FRAMSTAELLNING OCH DESS INNEHAOLLANDE PHARMACEUTICAL PRODUCT.
FI830399A0 (en) MJOELDRYGE ALKALOIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
FI883008A (en) 8 -ACYLAMINOERGOLIN, DESS FRAMSTAELLNING OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DETSAMMA.
FI822980L (en) FURANOKROMONDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
DE3887237D1 (en) Drug.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG